These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5558422)

  • 1. [Complement fixing ability of IgG and IgG subunits].
    Tanimoto K; Hirose S
    Arerugi; 1971; 20(6):424-30. PubMed ID: 5558422
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between rheumatoid factor and complement].
    Tanimoto K; Hirose S
    Arerugi; 1971; 20(6):466-80. PubMed ID: 5105160
    [No Abstract]   [Full Text] [Related]  

  • 3. The biologic activities of denatured human IgG and its heavy chains.
    Hirose SI
    J Immunol; 1970 Mar; 104(3):753-8. PubMed ID: 4190975
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein A from Staphylococcus aureus. IX. Complement-fixing activity of protein A-IgG complexes.
    Sjöquist J; Stålenheim G
    J Immunol; 1969 Sep; 103(3):467-73. PubMed ID: 5805432
    [No Abstract]   [Full Text] [Related]  

  • 5. Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG.
    MacLennan IC; Connell GE; Gotch FM
    Immunology; 1974 Feb; 26(2):303-10. PubMed ID: 4277464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of 19S antibodies in complement fixation. II. Selective inactivation of a complement-fixing site by urea.
    Cunniff RV; Cole HH; Stollar BD
    J Immunol; 1968 Oct; 101(4):695-701. PubMed ID: 5681649
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemistry and biologic activity of the complement system.
    Ruddy S
    Transplant Proc; 1974 Mar; 6(1):1-7. PubMed ID: 4361446
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation of binding from complete activation by use of heterologous components of complement.
    Koethe SM; Austen KF; Gigli I
    J Immunol; 1972 Apr; 108(4):1063-72. PubMed ID: 5023166
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein A from Staphylococcus aureus. X. Complement-fixing activity of complexes between protein A and myeloma IgG or papain fragments of IgG.
    Stålenheim G; Sjöquist J
    J Immunol; 1970 Oct; 105(4):944-8. PubMed ID: 4990440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complement fixation activity of immunoglobulin G in ethylene glycol solutions].
    Tétin SIu; Efetov KA; Troitskiĭ GV; Kozlov LV; Zinchenko AA
    Bioorg Khim; 1985 Aug; 11(8):1068-73. PubMed ID: 4062991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antilymphocytic activities of various immunoglobulins of sheep serum].
    Hainaut J; Boffa GA
    C R Seances Soc Biol Fil; 1973; 167(3):434-9. PubMed ID: 4798997
    [No Abstract]   [Full Text] [Related]  

  • 12. [The subgroups IgG I, II and 3 of human immunoglobulins G. II. Characterization of the subgroups with immunoelectrophoresis, heat denaturation and quantitative complement fixation test].
    Jungfer H
    Z Immunitatsforsch Exp Klin Immunol; 1971; 141(3):191-200. PubMed ID: 4251862
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on human IgD. II. The lack of skin sensitizing and complement fixing activities of immunoglobulin D.
    Henney CS; Welscher HD; Terry WD; Rowe DS
    Immunochemistry; 1969 May; 6(3):445-9. PubMed ID: 4182363
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune hemolysis: serial studies of the dissociability of IgG and IgM anti-Forssman antibodies using the C'la fixation and transfer technique.
    Linscott WD
    J Immunol; 1969 Apr; 102(4):986-92. PubMed ID: 5768199
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased complement efficiency through control of ionic strength and temperature.
    Linscott WD
    J Immunol; 1971 Sep; 107(3):698-704. PubMed ID: 5572091
    [No Abstract]   [Full Text] [Related]  

  • 16. The combination of IgM subunits and proteolytic IgG fragment by controlled formation of interchain disulphides.
    Konieczny L; Bobrzecka K; Laidler P; Rybarska J
    Haematologia (Budap); 1981; 14(1):95-9. PubMed ID: 7019031
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement fixing and macrophage opsonizing activities associated with beta2 microglobulin.
    Painter RH; Yasmeen D; Assimeh SN; Poulik MD
    Immunol Commun; 1974; 3(1):19-34. PubMed ID: 4132700
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral hepatitis, type A: identification by specific complement fixation and immune adherence tests.
    Krugman S; Friedman H; Lattimer C
    Trans Assoc Am Physicians; 1975; 88():94-100. PubMed ID: 1224443
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune hemolysis: an inter-species study.
    Linscott WD
    J Immunol; 1967 May; 98(5):991-1003. PubMed ID: 6024988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.